Malignant tumour of oesophagus
NEOSCOPE
Year Started: 2013
A randomised phase II study of induction chemotherapy followed by oxaliplatin/capecitabine or carboplatin/paclitaxel based pre-operative chemoradiation for resectable oesophageal adenocarcinoma
- Access:
- Open only through collaboration
- Type:
- Clinical Trial
- Status:
- Completed
- Consent restrictions:
-
No restrictions
Associated Data Type |
Procurement Timeframe |
Biomarker datasets |
3 - 6 months |
Clinical records |
3 - 6 months |
Followup records |
3 - 6 months |
Freezer temperature logs |
3 - 6 months |
Pathology records |
3 - 6 months |
Quality indicators |
3 - 6 months |
Male
Adult (> 40 years)
11 - 100 donors
Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
Tissue specimen |
Surgical procedure (procedure) |
RT |
N/A |
Affected |
100% |
Female
Adult (> 40 years)
11 - 100 donors
Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
Tissue specimen |
Surgical procedure (procedure) |
RT |
N/A |
Affected |
100% |
Male
Adult (> 40 years)
11 - 100 donors
Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
Serum |
|
-60°C to -85°C |
N/A |
Not applicable |
100% |
Female
Adult (> 40 years)
11 - 100 donors
Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
Serum |
|
-60°C to -85°C |
N/A |
Not applicable |
100% |
Malignant tumor of colon (disorder)
COPERNICUS
Year Started: 2012
A phase II single arm feasibility trial of neoadjuvant chemotherapy (NAC) with oxaliplatin/fluorouracil (OxMdG) then short-course preoperative radiotherapy (SCPRT) then immediate surgery in operable rectal cancer (ORC): COPERNICUS (NCT01263171).
- Access:
- Open only through collaboration
- Type:
- Clinical Trial
- Status:
- Completed
- Consent restrictions:
-
No restrictions
Associated Data Type |
Procurement Timeframe |
Biomarker datasets |
3 - 6 months |
Clinical records |
3 - 6 months |
Followup records |
3 - 6 months |
Freezer temperature logs |
3 - 6 months |
Pathology records |
3 - 6 months |
Physiological/biochemical measurements |
3 - 6 months |
Quality indicators |
3 - 6 months |
Male
Adult (> 40 years)
11 - 100 donors
Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
Tissue specimen |
Surgical procedure (procedure) |
RT |
N/A |
Affected |
100% |
Female
Adult (> 40 years)
11 - 100 donors
Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
Tissue specimen |
Surgical procedure (procedure) |
RT |
N/A |
Affected |
100% |
Male
Adult (> 40 years)
11 - 100 donors
Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
Plasma |
|
-60°C to -85°C |
N/A |
Not applicable |
100% |
Female
Adult (> 40 years)
11 - 100 donors
Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
Plasma |
|
-60°C to -85°C |
N/A |
Not applicable |
100% |